한글목차

세계 어류 백신 시장은 2025년 4억 1,000만 달러, 2032년에는 7억 6,460만 달러에 달할 것으로 예측되며, 2025-2032년간 연평균 9.3% 성장할 것으로 예상됩니다.

그림. 2025년 지역별 어류 백신 시장 점유율(%)

세계 어류 백신 시장은 양식 산업 증가와 치명적인 어류 질병 증가로 인해 지난 몇 년동안 꾸준히 성장하고 있습니다. 어류 백신은 어류 개체군을 전염병으로부터 보호하고 양식업자와 무역업체에게 큰 경제적 손실을 방지하는 데 도움이 됩니다. 백신은 식용 및 관상용으로 양식하는 어류에 대한 예방 접종을 돕습니다. 지속 가능한 어류 양식에 대한 수요 증가와 함께 해산물 소비가 증가함에 따라 가까운 미래에 전 세계적으로 어류 백신에 대한 수요가 증가할 것으로 예상됩니다.

시장 역학

세계 어패류 수요 증가로 인한 양식업 관행의 채택 증가는 어류 백신 시장의 성장을 가속할 수 있습니다. 특히 유럽과 북미에서 양식되는 연어류에서 바이브리오병, 에피테리오시스병 등 다양한 바이러스 및 세균 감염의 유행이 증가함에 따라 어류 백신의 매출이 증가할 것으로 예상됩니다. 그러나 어류 백신의 연구개발과 관련된 높은 비용과 새로운 어류 백신 출시에 대한 엄격한 규제는 시장 성장을 저해할 수 있습니다. 반면, 효율적인 내열성 어류 백신 개발을 위한 새로운 보조제 기술의 채택은 산업 제조업체에 유리한 비즈니스 기회를 제공할 수 있습니다.

본 조사의 주요 특징

• 세계의 어류 백신 시장을 상세하게 분석하여 2024년을 기준 연도로 하여 예측 기간(2025-2032년) 시장 규모와 연평균 성장률(CAGR)을 조사하여 전해드립니다.
• 다양한 부문에 걸친 잠재적 수익 창출 기회를 파악하고, 이 시장의 매력적인 투자 제안 매트릭스를 설명합니다.
• 또한 시장 성장 촉진요인, 억제요인, 기회, 신제품 출시 및 승인, 시장 동향, 지역별 전망, 주요 기업의 경쟁 전략 등에 대한 중요한 고찰을 제공합니다.
• 이 보고서는 기업 하이라이트, 제품 포트폴리오, 주요 하이라이트, 재무 성과, 전략 등의 매개 변수를 기반으로 세계 어류 백신 시장의 주요 기업을 프로파일링합니다.
• 이 보고서의 통찰력을 통해 마케팅 담당자와 기업 경영진은 향후 제품 출시, 유형화, 시장 확대, 마케팅 전술에 대한 정보에 입각한 의사결정을 내릴 수 있습니다.
• 세계 어류 백신 시장 보고서는 투자자, 공급업체, 제품 제조업체, 유통업체, 신규 시장 진출기업, 재무 분석가 등 이 산업의 다양한 이해관계자를 대상으로 합니다.
• 이해관계자들은 세계 어류 백신 시장을 분석할 때 사용되는 다양한 전략 매트릭스를 통해 의사결정을 용이하게 할 수 있습니다.

목차

제1장 조사 목적과 전제조건

• 조사 목적
• 전제조건
• 약어

제2장 시장 전망

• 보고서 설명
  • 시장 정의와 범위
• 주요 요약
• Coherent Opportunity Map (COM)

제3장 시장 역학, 규제, 동향 분석

• 시장 역학
  • 성장 촉진요인
  • 성장 억제요인
  • 기회
• 영향 분석
• 시장 동향
• 규제 시나리오
• 인수와 제휴 시나리오
• 자금조달과 투자
• PEST 분석
• Porter의 Five Forces 분석

제4장 세계의 어류 백신 시장 - 코로나바이러스(COVID-19) 팬데믹의 영향

• 전체적인 영향
• 정부 이니셔티브
• 시장에 대한 COVID-19의 영향

제5장 세계의 생선 백신 시장, 백신 유형별, 2020-2032년,(100만 달러)

• 서론
• 사균 백신
• 불활화 백신
• 약독화 백신
• 톡소이드 백신
• 아단위 백신
• 결합 백신
• 재조합 벡터 백신

제6장 세계의 어류 백신 시장, 적응증별, 2020-2032년,(100만 달러)

• 서론
• 설증
• 비브리오증
• 예르시니아증
• 장 패혈증
• 기타

제7장 세계의 생선 백신 시장, 투여 경로별, 2020-2032년,(100만 달러)

• 서론
• 주사
• Immersion
• 스프레이
• 경구

제8장 세계의 생선 백신 시장, 지역별, 2020-2032년,(100만 달러)

• 서론
• 북미
• 라틴아메리카
• 유럽
• 아시아태평양
• 중동
• 아프리카

제9장 경쟁 구도

• 기업 개요
  • Merck Animal Health(MSD Animal Health)
  • Zoetis
  • Elanco
  • Virbac
  • HIPRA
  • Veterquimica SA
  • Tecnovax
  • Phibro Animal Health Corporation
  • Ridgeway Biologicals Ltd.
  • Nisseiken Co., Ltd.
  • Aquatic Animal Health Ltd
  • Ictyogroup
  • Benchmark Holdings plc
  • Vaxxinova
  • Alpha BIoTech Ltd.
  • Vallee SA
  • Ringpu Biology
  • Nippon Zenyaku Kogyo Co., Ltd.
  • Chengdu Tech-bank Biological Products
  • Weiyuan Gene Tech

제10장 애널리스트 추천 사항

• 융성과 쇠퇴
• Coherent Opportunity Map

제11장 참고 문헌과 조사 방법

• 참고 문헌
• 조사 방법

영문목차

Global Fish Vaccine Market is estimated to be valued at USD 410.0 Mn in 2025 and is expected to reach USD 764.6 Mn by 2032, growing at a compound annual growth rate (CAGR) of 9.3% from 2025 to 2032.

Figure. Fish Vaccine Market Share (%), By Region 2025

Global fish vaccine market has witnessed steady growth in the past few years, owing to rise in aquaculture industry and increasing prevalence of deadly fish diseases. Fish vaccines help prevent fish populations from infectious diseases, thus, avoiding heavy economic losses to fish farmers and traders. Vaccines aid immunization of fish species that are raised through aquaculture practices for both food and ornamental purposes. Growing consumption of seafood along with rising demand for sustainable fish farming can boost demand for fish vaccines globally in the near future.

Market Dynamics:

Increasing adoption of aquaculture practices due to rising global seafood demand can drive the fish vaccine market growth. Increasing prevalence of various viral and bacterial infections such as Vibriosis and Epitheliocystis disease particularly among salmon species farmed in Europe and North America can boost sales of fish vaccines. However, high costs associated with fish vaccine R&D and stringent regulations pertaining to launch of new fish vaccines can hamper the market growth. Meanwhile, introduction of novel adjuvant technologies for developing efficient thermostable fish vaccines can provide lucrative business opportunities for manufacturers in the industry.

Key Features of the Study:

• This report provides in-depth analysis of the global fish vaccine market, and provides market size (USD Million) and compound annual growth rate (CAGR%) for the forecast period (2025-2032), considering 2024 as the base year
• It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
• This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
• It profiles key players in the global fish vaccine market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
• Key companies covered as a part of this study include Zoetis, Merck & Co., Inc., Phibro Animal Health Corporation, Virbac, Hipra, Veterquimica S.A., Tecnovax, Anthropic, HIPRA
• Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
• Global fish vaccine market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
• Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global fish vaccine market

Detailed Segmentation-

• By Vaccine Type:
  • Killed Vaccine
  • Inactivated Vaccine
  • Attenuated Vaccine
  • Toxoid Vaccine
  • Subunit Vaccine
  • Conjugate Vaccine
  • Recombinant Vector Vaccines
• By Indication:
  • Furunculosis
  • Vibriosis
  • Yersiniosis
  • Enteric septicaemia
  • Others
• By Route of Administration:
  • Injection
  • Immersion
  • Spray
  • Oral
• Region:
  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East
  • Africa
• Company Profiles:
  • Merck Animal Health (MSD Animal Health)
  • Zoetis
  • Elanco
  • Virbac
  • HIPRA
  • Veterquimica S.A.
  • Tecnovax
  • Phibro Animal Health Corporation
  • Ridgeway Biologicals Ltd.
  • Nisseiken Co., Ltd.
  • Aquatic Animal Health Ltd
  • Ictyogroup
  • Benchmark Holdings plc
  • Vaxxinova
  • Alpha Biotech Ltd.
  • Vallee S.A.
  • Ringpu Biology
  • Nippon Zenyaku Kogyo Co., Ltd.
  • Chengdu Tech-bank Biological Products
  • Weiyuan Gene Tech

Table of Contents

1. Research Objectives and Assumptions

• Research Objectives
• Assumptions
• Abbreviations

2. Market Purview

• Report Description
  • Market Definition and Scope
• Executive Summary
  • Market Snapshot, By Vaccine Type
  • Market Snapshot, By Indication
  • Market Snapshot, By Route of Administration
  • Market Snapshot, By Region
• Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

• Market Dynamics
  • Drivers
  • Restraints
  • Opportunities
• Impact Analysis
• Market Trends
• Key Developments
• Regulatory Scenario
• Acquisitions and Partnerships Scenario
• Funding and Investments
• PEST Analysis
• Porter's Analysis

4. Global Fish Vaccine Market - Impact of Coronavirus (COVID-19) Pandemic

• Overall Impact
• Government Initiatives
• COVID-19 Impact on the Market

5. Global Fish Vaccine Market, By Vaccine Type, 2020 - 2032, (USD Mn)

• Overview
  • Market Share Analysis, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, 2020 - 2032
  • Segment Trends
• Killed Vaccine
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
• Inactivated Vaccine
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
• Attenuated Vaccine
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
• Toxoid Vaccine
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
• Subunit Vaccine
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
• Conjugate Vaccine
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
• Recombinant Vector Vaccines
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)

6. Global Fish Vaccine Market, By Indication, 2020 - 2032, (USD Mn)

• Overview
  • Market Share Analysis, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, 2020 - 2032
  • Segment Trends
• Furunculosis
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
• Vibriosis
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
• Yersiniosis
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
• Enteric septicaemia
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
• Others
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)

7. Global Fish Vaccine Market, By Route of Administration, 2020 - 2032, (USD Mn)

• Overview
  • Market Share Analysis, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, 2020 - 2032
  • Segment Trends
• Injection
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
• Immersion
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
• Spray
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
• Oral
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)

8. Global Fish Vaccine Market, By Region, 2020 - 2032, (USD Mn)

• Introduction
  • Market Share Analysis, By Region, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, For Region, 2020-2032
  • Regional Trends
• North America
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Vaccine Type, 2020 - 2032, (USD Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Indication, 2020 - 2032, (USD Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2020 - 2032, (USD Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (USD Mn)
    • U.S.
    • Canada
• Latin America
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Vaccine Type, 2020 - 2032, (USD Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Indication, 2020 - 2032, (USD Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2020 - 2032, (USD Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (USD Mn)
    • Brazil
    • Mexico
    • Argentina
    • Rest of Latin America
• Europe
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Vaccine Type, 2020 - 2032, (USD Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Indication, 2020 - 2032, (USD Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2020 - 2032, (USD Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (USD Mn)
    • U.K.
    • Germany
    • Italy
    • France
    • Spain
    • Russia
    • Rest of Europe
• Asia Pacific
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Vaccine Type, 2020 - 2032, (USD Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Indication, 2020 - 2032, (USD Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2020 - 2032, (USD Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (USD Mn)
    • China
    • India
    • Japan
    • ASEAN
    • Australia
    • South Korea
    • Rest of Asia Pacific
• Middle East
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Vaccine Type, 2020 - 2032, (USD Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Indication, 2020 - 2032, (USD Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2020 - 2032, (USD Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (USD Mn)
    • GCC
    • Israel
    • Rest of Middle East
• Africa
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Vaccine Type, 2020 - 2032, (USD Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Indication, 2020 - 2032, (USD Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2020 - 2032, (USD Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2020 - 2032, (USD Mn)
    • North Africa
    • Central Africa
    • South Africa

9. Competitive Landscape

• Company Profiles
  • Merck Animal Health (MSD Animal Health)
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Zoetis
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Elanco
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Virbac
  • HIPRA
  • Veterquimica S.A.
  • Tecnovax
  • Phibro Animal Health Corporation
  • Ridgeway Biologicals Ltd.
  • Nisseiken Co., Ltd.
  • Aquatic Animal Health Ltd
  • Ictyogroup
  • Benchmark Holdings plc
  • Vaxxinova
  • Alpha Biotech Ltd.
  • Vallee S.A.
  • Ringpu Biology
  • Nippon Zenyaku Kogyo Co., Ltd.
  • Chengdu Tech-bank Biological Products
  • Weiyuan Gene Tech

10. Analyst Recommendations

• Wheel of Fortune
• Analyst View
• Coherent Opportunity Map

11. References and Research Methodology

• References
• Research Methodology
• About Us and Sales Contact